Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0095 EUR | -.--% | +46.15% | -5.00% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.89M 4.51M |
---|---|---|---|---|---|
Net income 2021 | -5M -4.61M | Net income 2022 | -5M -4.61M | EV / Sales 2021 | - |
Net cash position 2021 | 6.59M 6.08M | Net cash position 2022 | 3.7M 3.41M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.23
x | P/E ratio 2022 |
-0.87
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.54% |
1 week | +46.15% | ||
1 month | +58.33% | ||
3 months | -34.48% | ||
6 months | -62.00% | ||
Current year | -5.00% |
Date | Price | Change |
---|---|---|
24-05-31 | 0.0095 | -.--% |
24-05-30 | 0.0095 | -.--% |
24-05-29 | 0.0095 | -.--% |
24-05-28 | 0.0095 | +46.15% |
24-05-27 | 0.0065 | -.--% |
Real-time Irish S.E., May 31, 2024 at 11:55 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.00% | 840K | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OVXA Stock